PMID: 9444525Jan 1, 1997Paper

Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension

Fundamental & Clinical Pharmacology
P VerwaerdeG Portolan

Abstract

Yohimbine has been proposed for the treatment of neurogenic orthostatic hypotension; however, no controlled trial has been performed in experimental models of orthostatic hypotension or in patients with autonomic failure. The aim of the present study was to compare the effects of yohimbine (0.05 mg/kg, intravenously [i.v.]) and placebo (saline) in a new model of neurogenic orthostatic hypotension obtained by sinoaortic denervation (SAD) in chloralose-anaesthetized dogs. Blood pressure, heart rate, noradrenaline plasma levels and systolic blood pressure and heart rate short-term variabilities (calculated on low frequency [40-50 MHz] and high frequency [390-490 MHz] bands) were measured in supine position and after a 10 min 80 degrees head-up tilting. The drugs were administered in a double-blind cross-over randomized fashion. The head-up tilting performed in normal animals increased diastolic blood pressure (+12 +/- 4 mmHg), heart rate (+39 +/- 12 beats per minute [bpm]), the low frequency band of systolic blood pressure and noradrenaline plasma level, without changing systolic blood pressure or heart rate variability. In SAD dogs, a marked fall in systolic (-80 +/- 11 mmHg) and diastolic (-43 +/- 4 mmHg) blood pressures was obs...Continue Reading

References

Jul 1, 1992·Trends in Pharmacological Sciences·M BerlanM Lafontan
Oct 1, 1992·Acta Physiologica Scandinavica·A E HedmanM O Hakumäki
Feb 1, 1992·Trends in Pharmacological Sciences·M PaganiA Malliani
Jan 1, 1992·Acta Physiologica Scandinavica·T ShibamotoS Koyama
Jan 1, 1992·British Journal of Pharmacology·M F PoncetP Montastruc
Apr 1, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·G TavernierJ L Montastruc
Apr 1, 1992·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·J M SenardJ L Montastruc
Sep 1, 1990·Journal of Cardiovascular Pharmacology·M L GrichoisJ L Elghozi
Jun 1, 1991·Journal of Cardiovascular Pharmacology·J L ElghoziF Janvier
Aug 1, 1991·Circulation·A MallianiS Cerutti
Jan 1, 1990·European Journal of Clinical Pharmacology·J GalitzkyM Berlan
Dec 1, 1990·European Journal of Clinical Investigation·J M SenardP Montastruc
Jan 1, 1990·Drugs·R A Ahmad, R D Watson
Jan 1, 1989·Fundamental & Clinical Pharmacology·P ValetP Montastruc
Mar 1, 1986·The American Journal of Medicine·J OnrotD Robertson
May 1, 1994·Journal of Clinical Pharmacology·I BiaggioniD Robertson
Nov 11, 1993·The New England Journal of Medicine·D RobertsonR M Robertson
Apr 1, 1996·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·P VerwaerdeP Montastruc
Apr 1, 1996·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·H Kaufmann
Jan 1, 1996·Fundamental & Clinical Pharmacology·J M Senard, J L Montastruc

❮ Previous
Next ❯

Citations

Dec 18, 2001·Pharmacology & Therapeutics·S W TamM Wyllie
Jan 12, 2001·Journal of the American College of Cardiology·O OldenburgA Kribben
Dec 17, 2002·Current Opinion in Pharmacology·Olaf OldenburgMichael V Cohen
Jan 18, 2007·Fundamental & Clinical Pharmacology·Géraldine JourdanJean-Michel Senard
Nov 1, 2018·The Journal of Nutrition, Health & Aging·A Shams, J E Morley
Sep 21, 2001·Fundamental & Clinical Pharmacology·M PelatJ L Montastruc
Mar 23, 2011·Toxicon : Official Journal of the International Society on Toxinology·Arhamatoulaye MaïgaNicolas Gilles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.